Key result
Skinfold thickness SDS is linked to a ~12-fold higher insulin resistance risk in pediatric obesity.
Why the study?
Do skinfold thickness and MUAC predict insulin resistance in pediatric patients with obesity?
Cross-Sectional (n=171)
Do skinfold thickness and MUAC predict insulin resistance in pediatric patients with obesity?
Standardized measurements of skinfold thickness and MUAC (SDS and percentiles) are strong, practical, and non-invasive markers for predicting insulin resistance in pediatric patients with obesity.
Introduction Early detection of insulin resistance (IR) in children is essential to prevent long‐term metabolic complications. Simple anthropometric measures—mid‐upper arm circumference (MUAC) and skinfold thickness—are widely used, but their predictive value, especially when age‐standardized, remains unclear. This study aimed to evaluate the performance of raw, SDS, and percentile MUAC and skinfold measurements in predicting IR in patients with obesity and adolescents. Methods A cross‐sectional study was conducted with 171 participants with obesity aged 6–18 years. Anthropometric measurements were recorded and converted to SDS and percentile values. Insulin resistance was evaluated using HOMA‐IR with pubertal‐stage–adjusted cutoffs. Logistic regression and ROC analyses were applied. Results Insulin resistance was present in 56.1% of participants. Both MUAC and skinfold thickness showed significant positive associations with IR; however, standardized measures (SDS and percentiles) demonstrated markedly stronger predictive value than raw measurements. Skinfold thickness SDS emerged as the strongest independent predictor of IR (OR = 12.04, p < 0.001), followed by MUAC SDS (OR = 7.28, p < 0.001). ROC analysis showed excellent discriminatory power for skinfold SDS (AUC = 0.82), with an optimal cutoff of 1.48 (76% sensitivity, 80% specificity). MUAC SDS also performed well (AUC = 0.76; cutoff = 1.10). Conclusion Skinfold thickness SDS and MUAC SDS are strong, practical, and non‐invasive markers for predicting insulin resistance in paediatric patients with obesity. Standardized measurements clearly outperform raw values and should be integrated into routine clinical assessment to enhance early detection of metabolic risk.
No takes yet. Share an insight, caveat, or question.
Kaya et al. (2026) conducted a cross-sectional in Obesity (n=171). Skinfold thickness SDS and MUAC SDS vs. Raw measurements was evaluated on Insulin resistance (OR 12.04, p=<0.001). Skinfold thickness SDS was a strong independent predictor of insulin resistance in pediatric patients with obesity (OR 12.04, p<0.001), outperforming raw measurements.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from Journal of Paediatrics and Child Health